Alameda, CA.-- (BUSINESS WIRE) -- December 7, 2006"Advanced Cell Technology, Inc.'s (OTCBB:"ACTC":http://finance.yahoo.com/q?s=actc.ob&d=t - "News":http://finance.yahoo.com/q/h?s=actc.ob) Robert Lanza, M.D., VP of Research and Scientific Development, will deliver the keynote address at the University of Florida's Vision Research Symposium, titled "Advances in the Use of Stem Cells for Repair and Regeneration of the Eye,�” December 7, 2006, at 12:10 PM, at the Hilton University of Florida Conference Center, Gainesville, Florida. Dr. Lanza's presentation is titled "The Use of Embryonic Stem Cells in Regenerative Medicine.” The recent progress that has been made in using embryonic stem-cell derived cells to rescue visual function in animals will be discussed, as well as the scientific promise --and challenges -- that remain before these and other human stem cell therapies can enter the clinic.
A downloadable copy of the presentation will be available on the company's website at "www.advancedcell.com/conference-presentations":http://www.advancedcell.com/conference-presentations
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit "http://www.advancedcell.com":http://www.advancedcell.com .
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
The Investor Relations Group
Investors: "James Carbonara":mailto:firstname.lastname@example.org, 212-825-3210
Media: "Bill Douglass":mailto:email@example.com, 212-825-3210
Trilogy Capital Partners
"Paul Karon":mailto:firstname.lastname@example.org, 800-592-6067
Source: Advanced Cell Technology, Inc.